Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024:2720:165-176.
doi: 10.1007/978-1-0716-3469-1_12.

Formulation of Chitosan-Zein Nano-in-Microparticles for Oral DNA Delivery

Kari Heck  1 , Eric Farris  2 , Angela K Pannier  3
Affiliations

Formulation of Chitosan-Zein Nano-in-Microparticles for Oral DNA Delivery

Kari Heck et al. Methods Mol Biol. 2024.

Abstract

Gene delivery via the oral route offers a promising strategy for improving DNA vaccination and gene-based therapy outcomes. The noninvasive nature of oral delivery lends to ease of dosing, which can facilitate convenience and patient compliance. Moreover, oral administration allows for both local and systemic production of therapeutic genes or, in the case of DNA vaccination, mucosal and systemic immunity. Here, we describe the methods to produce a dual biomaterial, oral DNA delivery system composed of chitosan (CS) and zein (ZN). In this system, CS serves to encapsulate and deliver DNA cargo to intestinal cells in the form of CS-DNA nanoparticles (CS-DNA NPs), while ZN is used to form a protective matrix around the CS-DNA NPs that prevent degradation during gastric transit but then degrades to release the CS-DNA NPs for transfection upon entry into the intestines. These particles have demonstrated the ability to effectively protect cargo DNA from simulated gastric degradation in vitro and mediate transgene production in vivo, making them an effective oral gene delivery system.

Keywords: Chitosan; Gene delivery; Gene therapy; Nano-in-microparticles; Oral delivery; Zein.

PubMed Disclaimer

References

    1. des Rieux A, Fievez V, Garinot M, Schneider YJ, Preat V (2006) Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release 116(1):1–27. https://doi.org/10.1016/j.jconrel.2006.08.013 - DOI - PubMed
    1. Guliyeva U, Oner F, Ozsoy S, Haziroglu R (2006) Chitosan microparticles containing plasmid DNA as potential oral gene delivery system. Eur J Pharm Biopharm 62(1):17–25. https://doi.org/10.1016/j.ejpb.2005.08.006 - DOI - PubMed
    1. Alexis F, Pridgen E, Molnar LK, Farokhzad OC (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5(4):505–515. https://doi.org/10.1021/mp800051m - DOI - PubMed - PMC
    1. O’Neill MJ, Bourre L, Melgar S, O’Driscoll CM (2011) Intestinal delivery of non-viral gene therapeutics: physiological barriers and preclinical models. Drug Discov Today 16(5–6):203–218. https://doi.org/10.1016/j.drudis.2011.01.003 - DOI - PubMed
    1. Lycke N (2012) Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol 12(8):592–605. https://doi.org/10.1038/nri3251 - DOI - PubMed

Publication types

LinkOut - more resources